The atherosclerosis-cancer axis: the shared immunotherapeutic potential of CBL inhibition


Journal article


K. Jarr, L. Luo, N. Leeper
European Heart Journal, 2025

DOI: 0.1093/eurheartj/ehaf624.

Cite

Cite

APA   Click to copy
Jarr, K., Luo, L., & Leeper, N. (2025). The atherosclerosis-cancer axis: the shared immunotherapeutic potential of CBL inhibition. European Heart Journal. https://doi.org/0.1093/eurheartj/ehaf624.


Chicago/Turabian   Click to copy
Jarr, K., L. Luo, and N. Leeper. “The Atherosclerosis-Cancer Axis: the Shared Immunotherapeutic Potential of CBL Inhibition.” European Heart Journal (2025).


MLA   Click to copy
Jarr, K., et al. “The Atherosclerosis-Cancer Axis: the Shared Immunotherapeutic Potential of CBL Inhibition.” European Heart Journal, 2025, doi:0.1093/eurheartj/ehaf624.


BibTeX   Click to copy

@article{k2025a,
  title = {The atherosclerosis-cancer axis: the shared immunotherapeutic potential of CBL inhibition},
  year = {2025},
  journal = {European Heart Journal},
  doi = {0.1093/eurheartj/ehaf624.},
  author = {Jarr, K. and Luo, L. and Leeper, N.}
}